Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPEFER: Continuous Versus Periodic Intravenous Iron Supplementation in Hemodialysis Patients
NCT02198495Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2014
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in anemia of chronic kidney disease (CKD-A), sponsored by Medical University of Vienna. Started Sep 2014; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02198495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198495.